yingweiwo

TLR

TLR

TLR related products

Structure Cat No. Product Name CAS No. Product Description
1V209 V40665 1V209 1062444-54-5 1V209 is a novel and potent Toll-like receptor 7 (TLR7) agonistwithanti-tumor activity.
3D-Monophosphoryl Lipid (12,16) free acid V125364 3D-Monophosphoryl Lipid (12,16) free acid 220048-49-7 3D-Monophosphoryl Lipid (12,16) free acid is a TLR4 agonist that can be used as a vaccine adjuvant to enhance the immunogenicity of vaccines.
ABB071 V128024 ABB071 ABB071 is a humanized anti-CD180 monoclonal antibody.
ABC-015 V128032 ABC-015 ABC-015 is a human monoclonal antibody (mAb) that targets KLRG1.
ABR-238901 V74342 ABR-238901 1638200-22-2 ABR-238901 is an orally bioactive S100A8/A9 blocker that can inhibit the interaction of S100A8/A9 with its receptors RAGE (receptor for advanced glycation end products) and TLR4 (toll-like receptor 4).
Agatolimod sodium (ODN 7909; PF-3512676; CpG 7909) V74373 Agatolimod sodium (ODN 7909; PF-3512676; CpG 7909) 541547-35-7 Agatolimod sodium (ODN 7909) is a class B CpG ODN and a< B >TLR9 agonist.
AXC-715 hydrochloride V51784 AXC-715 hydrochloride 2490497-93-1 AXC-715 (T785) HCl is a TLR7/TLR8 dual agonist obtained from patent WO2020168017 A1.
AYK005 V103689 AYK005 3031612-93-5 AYK005 is a TLR7/8 type vaccine adjuvant.
Biotin-labeled ODN 1585 sodium V78440 Biotin-labeled ODN 1585 sodium Biotin-labeled ODN 1585 (sodium) is a potent inducer of IFN and TNFα production.
Cobitolimod sodium scrambled negative control V132006 Cobitolimod sodium scrambled negative control The Cobitolimod sodium scrambled negative control is a negative control with the sequence of Cobitolimod sodium scrambled.
CpG ODN 10101 sodium V87020 CpG ODN 10101 sodium CpG ODN 10101 sodium is a synthetic oligodeoxynucleotide (ODN) that is a Toll-like receptor 9 (TLR9) agonist.
Creatine ethyl ester V132466 Creatine ethyl ester 15366-29-7 Creatine ethyl ester is a commonly used and readily available form of creatine in supplements.
CU-CPT-8m V3815 CU-CPT-8m 125079-83-6 CU-CPT-8m is a novel, potent and specific antagonist ofToll-like receptor 8 (TLR8)with immunomodulatory effects.
CU-CPT-9a V3816 CU-CPT-9a 2165340-32-7 CU-CPT-9a, an analog ofCU-CPT-8m, is a potent and specificantagonist/inhibitor of TLR8 (Toll-like receptor 8) (IC50 = 0.5 nM) with the potential to be used for treating autoimmune diseases.
CU-CPT-9b V3817 CU-CPT-9b 2162962-69-6 CU-CPT-9b, an analog ofCU-CPT-8m and CU-CPT-9a, is a specificantagonist of TLR8 (Toll-like receptor 8) with IC50 of 0.7 nM.
CU-CPT17e V3818 CU-CPT17e 2109805-75-4 CU-CPT17e is a multi-TLR (Toll-like receptor) agonist that activates TLR3, TLR8, and TLR9 with immunomodulatory activities.
E6446 HCl V20340 E6446 HCl 1345675-25-3 E6446 is a synthetic antagonist of nucleic acid-sensing TLRs.
FITC-labeled Agatolimod sodium V79421 FITC-labeled Agatolimod sodium FITC-labeled Agatolimod (sodium) is a class B CpG ODN and a TLR9 agonist.
FITC-labeled ODN 1018 sodium V77015 FITC-labeled ODN 1018 sodium FITC-labeled ODN 1018 (sodium) is a TLR9 agonist.
FITC-labeled ODN 1826 sodium V79424 FITC-labeled ODN 1826 sodium FITC-labeled ODN 1826 (sodium) is a class B CpG ODN and a TLR9 agonist.
Contact Us